Has Dana Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,124 in general payments to Dana Lin, MD across 180 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dana Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dana Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dana Lin, MD

Foot & Ankle Surgery · Costa Mesa, CANPI 1811481914

Payments from drug & device makers

$15,124in general payments, 2019–2025

Across 180 payments — averaging $84.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$4K
Paragon 28, Inc.$3K
Integra Lifesciences Corporation$1K
Arthrex$1K
Treace Medical Concepts, Inc.$1K
Smith+Nephew$511
plus $3K from 22 others

What the payments were for

Speaking & faculty fees$120%
Travel & lodging$5,30935%
Food & beverage$9,59463%
Education$2101%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	65	$3,819
Paragon 28, Inc.	17	$3,400
Integra Lifesciences Corporation	19	$1,489
Arthrex	6	$1,243
Treace Medical Concepts, Inc.	12	$1,198
Smith+Nephew	10	$511
Gilead	5	$411
Inari Medical, Inc.	2	$403
Biotissue Holdings Inc.	6	$347
Amgen(2 entities)	4	$282
Linvatec Corporation	2	$212
Medical Device Business Services, Inc.	1	$210
Johnson & Johnson(2 entities)	3	$201
Trimed, Inc.	1	$178
Paratek Pharmaceuticals, Inc.	5	$166
Abbott	2	$150
In2bones USA, LLC	1	$146
Novo Nordisk	2	$141
Merck	3	$127
Organogenesis Inc.	1	$101
Averitas Pharma Inc.	1	$100
Saxum Surgical, Inc.	2	$61
Dexcom, Inc.	2	$58
Conmed Corporation	1	$56
Zimmer Biomet	2	$50
Tactile Systems Technology Inc	3	$38
Acell, Inc.	1	$16
Aroa Biosurgery Incorporated	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$3,371
Portfolio$1,589
INTEGRA DERMAL REGENERATION TEMPLATE$1,124
PRIMATRIX$1,124
Lapiplasty System$879
ANCHORAGE$543
EASY CLIP$543
AUGMENT INJECTABLE$429
VARIAX$426
FLOWTRIEVER CATHETER, S$403
CT THROMBECTOMY SYSTEM KIT$403
STAR$305
HOFFMANN$301
KRYSTEXXA$247
TMC NANOPLASTY SYSTEM$193
Tools - WS3$178
T2$169
PROstep$153
BioBrace 23mm$151
Reference Toe System$146

How this compares

$15,124 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California →

Medicare billing

Part B allowed, 2024

$6,496

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	65	$1,508
Clotrimazole	29	$534
Ciclopirox	20	$510
Diclofenac Sodium	21	$331
Gabapentin	24	$189
Mupirocin	20	$164

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Costa Mesa

John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K
Andrew HsuOrange$456K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →